Portfolio Companies 2026 for Forbion: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Forbion accounts for 53 tracked companies with verified cap-table data, 53 of which disclose round sizes totalling $7.6B. The median disclosed raise is $124M, and the largest is MapLight Therapeutics at $699M, ahead of Verdiva Bio ($411M) and AGTC ($290M).
The names that recur most often on these portfolio cap tables are Forbion (53 companies), Novartis Venture Fund (9 companies), Novo Holdings (7 companies), RA Capital Management (6 companies), Sofinnova Partners (6 companies), Syncona (5 companies). By latest disclosed round, the market skews Series A (23), Series B (16), Series D (3), IPO (3).
Companies tracked: 53
Disclosed funding total: $7.6B across 53 companies
Median disclosed raise: $124M
Largest raise: MapLight Therapeutics — $699M
Stage mix: Series A 23 · Series B 16 · Series D 3 · IPO 3
